Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AFP”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Not applicableLooking for participantsNCT07469319
What this trial is testing

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Cirrhosis
University of Aarhus 617
Post-approval studies (Phase 4)UnknownNCT03402165
What this trial is testing

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Sherief Abd-Elsalam 1,200
Testing effectiveness (Phase 2)UnknownNCT04098796
What this trial is testing

PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaAFP
China Medical University, China 30
Early research (Phase 1)Looking for participantsNCT06515314
What this trial is testing

HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors

Who this might be right for
Hepatic Cell Carcinoma
Shanghai Ruiliyuan Biotechnology Co., Ltd. 12
Not applicableStudy completedNCT04477720
What this trial is testing

Retrospective Analysis of De-identified Deceased HCC Patients

Who this might be right for
Survival
Carr, Brian 1,000
Early research (Phase 1)Study completedNCT02589119
What this trial is testing

Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP)

Who this might be right for
Perianal FistulaCryptoglandular Perianal Fistula
Mayo Clinic 15
Early research (Phase 1)Study completedNCT03209700
What this trial is testing

Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas

Who this might be right for
Perianal FistulaCryptoglandular Perianal FistulaCrohn's Perianal Fistula
William A. Faubion, M.D. 7
Early research (Phase 1)Ended earlyNCT03349255
What this trial is testing

Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasms+1 more
Aeon Therapeutics (Shanghai) Co., Ltd. 3
Not applicableStudy completedNCT00545441
What this trial is testing

Clinical Trial Comparing Surgisis AFP to Advancement Flap for the Repair of Anal Fistulas

Who this might be right for
Anal Fistula
Cook Group Incorporated 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06973330
What this trial is testing

Sintilimab Plus Apatinib and SOX as First-line Treatment in Patients With AFP Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
AFP Gastric or Gastroesophageal Junction Adenocarcinoma
Anhui Provincial Cancer Hospital 40
Not applicableStudy completedNCT02272504
What this trial is testing

A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers

Who this might be right for
CirrhosisChronic Liver Diseases
Wako Life Sciences 2,500
Not applicableUnknownNCT04082507
What this trial is testing

Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta

Who this might be right for
Placenta Accreta
rasha medhat abdul-hady 150
Not applicableStudy completedNCT03775863
What this trial is testing

AFP Model and Liver Transplantation.

Who this might be right for
Liver CarcinomaLiver Transplant Disorder
Austral University, Argentina 1,200
Not applicableUnknownNCT03460080
What this trial is testing

Diagnostic Value of AFP-L3 and PIVKA-II in HCC

Who this might be right for
Hepatocellular Carcinoma
Hanoi Medical University 200
Not applicableUnknownNCT01350167
What this trial is testing

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

Who this might be right for
CirrhosisEnd Stage Liver DiseaseHepatitis C
Minneapolis Veterans Affairs Medical Center 300
Not applicableStudy completedNCT03311152
What this trial is testing

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Central Hospital, Nancy, France 639
Not applicableActive Not RecruitingNCT05756699
What this trial is testing

Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma

Who this might be right for
Liver Cirrhosis
Seoul National University Hospital 200
Not applicableStudy completedNCT01361061
What this trial is testing

AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver

Who this might be right for
Liver Cirrhosis
University Hospital Freiburg 450
Not applicableUnknownNCT01492127
What this trial is testing

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

Who this might be right for
Hepatocellular CarcinomaCirrhosis
University Hospital, Montpellier 64
Not applicableUnknownNCT04414956
What this trial is testing

Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaSurveillance
Korea University 1,418
Load More Results